Some States Object to Proposed Opioid Deal with OxyContin Maker

pills, drugs, manufacturing

Some states are objecting to a proposed deal with OxyContin maker Purdue Pharma to resolve more than 2,000 lawsuits over the company’s role in the opioid crisis, The Wall Street Journal reports.

Attorneys general from states including New York, Connecticut and Massachusetts say the potential $12 billion deal does not bring in enough funding. Almost every state, as well as thousands of cities and counties, sued Purdue. The suits claim the company’s aggressive promotion of OxyContin helped to ignite the opioid addiction epidemic.

The states have several concerns, the article notes. Among these are the deal’s reliance on future drug sales, how much money will be guaranteed, and the contribution of the Sackler family, which owns Purdue. Under the current proposal, Purdue would file for bankruptcy, and would become a public benefit corporation run by trustees. The proposal would include $3 billion in cash from the Sacklers.

Heroin & the Opioid Epidemic: From Understanding to Action

Heroin and other opioids are ravaging communities across America. Heroin-related deaths increased by more than five times between 2010 and 2017, and drug deaths from fentanyl and other synthetic opioids are seeing a sharp rise as well.


Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *